| Browse All

LivaNova PLC (LIVN)

Healthcare | Medical Devices | London, United Kingdom | NasdaqGS
67.12 USD +2.11 (3.246%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 67.06 -0.06 (-0.061%) ⇩ (April 17, 2026, 5:48 p.m. EDT)

Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 18, 2026, 1:19 p.m. EDT

Conflicting signals: bullish options activity clashes with negative fundamentals and high debt, creating a volatile short-term landscape with no clear directional edge.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.030211
MSTL0.030577
AutoETS0.030633
AutoTheta0.030679

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 80%
H-stat 0.20
Ljung-Box p 0.000
Jarque-Bera p 0.491
Excess Kurtosis 0.02
Attribute Value
Sector Healthcare
Debt to Equity Ratio 36.148
Revenue per Share 25.446
Market Cap 3,670,784,512
Forward P/E 14.68
Beta 0.97
Profit Margins -17.47%
Website https://www.livanova.com

As of April 18, 2026, 1:19 p.m. EDT: Options speculators show mixed positioning: elevated put IV (3.27) at ATM 65.0 suggests bearish hedging, while call OI (62.5/67.5 strikes) indicates bullish bias. Recent price action (4-week +7.2%) conflicts with low forecasting model confidence (0.0026% directional prediction). Calls show stronger open interest vs. puts, but volatility remains elevated.


Info Dump

Attribute Value
52 Week Change 0.9393239
Address1 20 Eastbourne Terrace
All Time High 131.54
All Time Low 32.48
Ask 67.26
Ask Size 1
Audit Risk 7
Average Analyst Rating 1.7 - Buy
Average Daily Volume10 Day 731,800
Average Daily Volume3 Month 820,812
Average Volume 820,812
Average Volume10Days 731,800
Beta 0.972
Bid 66.99
Bid Size 1
Board Risk 1
Book Value 21.958
City London
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 3
Country United Kingdom
Crypto Tradeable 0
Currency USD
Current Price 67.12
Current Ratio 1.363
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 68.04
Day Low 65.98
Debt To Equity 36.148
Display Name LivaNova
Earnings Call Timestamp End 1,778,068,800
Earnings Call Timestamp Start 1,778,068,800
Earnings Growth -0.456
Earnings Quarterly Growth -0.447
Earnings Timestamp 1,778,070,600
Earnings Timestamp End 1,778,070,600
Earnings Timestamp Start 1,778,070,600
Ebitda 257,655,008
Ebitda Margins 0.18562001
Enterprise To Ebitda 13.464
Enterprise To Revenue 2.499
Enterprise Value 3,469,004,544
Eps Current Year 4.2105
Eps Forward 4.5722
Eps Trailing Twelve Months -4.45
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 64.8294
Fifty Day Average Change 2.2906036
Fifty Day Average Change Percent 0.03533279
Fifty Two Week Change Percent 93.93239
Fifty Two Week High 71.92
Fifty Two Week High Change -4.7999954
Fifty Two Week High Change Percent -0.06674076
Fifty Two Week Low 34.24
Fifty Two Week Low Change 32.88
Fifty Two Week Low Change Percent 0.96028036
Fifty Two Week Range 34.24 - 71.92
Financial Currency USD
First Trade Date Milliseconds 1,445,261,400,000
Float Shares 50,956,745
Forward Eps 4.5722
Forward P E 14.680024
Free Cashflow 834,246,656
Full Exchange Name NasdaqGS
Full Time Employees 3,300
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.68014
Gross Profits 944,070,016
Has Pre Post Market Data 1
Held Percent Insiders 0.0039399997
Held Percent Institutions 1.0834401
Implied Shares Outstanding 54,689,876
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova's aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Long Name LivaNova PLC
Market us_market
Market Cap 3,670,784,512
Market State CLOSED
Max Age 86,400
Message Board Id finmb_27283
Most Recent Quarter 1,767,139,200
Net Income To Common -242,471,008
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 3,668,596,882
Number Of Analyst Opinions 11
Open 65.98
Operating Cashflow 254,340,000
Operating Margins 0.12968001
Overall Risk 2
Payout Ratio 0.0
Peg Ratio 0.75
Phone 44 20 3325 0660
Post Market Change -0.06060028
Post Market Change Percent -0.09028647
Post Market Price 67.0594
Post Market Time 1,776,462,489
Previous Close 65.01
Price Eps Current Year 15.941101
Price Hint 2
Price To Book 3.0567448
Price To Sales Trailing12 Months 2.6445565
Profit Margins -0.17468001
Quick Ratio 1.054
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.72727
Region US
Regular Market Change 2.11
Regular Market Change Percent 3.24566
Regular Market Day High 68.04
Regular Market Day Low 65.98
Regular Market Day Range 65.98 - 68.04
Regular Market Open 65.98
Regular Market Previous Close 65.01
Regular Market Price 67.12
Regular Market Time 1,776,456,001
Regular Market Volume 758,420
Return On Assets 0.05169
Return On Equity -0.19242
Revenue Growth 0.121
Revenue Per Share 25.446
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 3
Shares Outstanding 54,689,876
Shares Percent Shares Out 0.0545
Shares Short 2,983,194
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 2,399,324
Short Name LivaNova PLC
Short Percent Of Float 0.0633
Short Ratio 3.7
Source Interval 15
Symbol LIVN
Target High Price 90.0
Target Low Price 67.0
Target Mean Price 79.18182
Target Median Price 80.0
Total Cash 635,552,000
Total Cash Per Share 11.621
Total Debt 433,772,000
Total Revenue 1,388,052,992
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -4.45
Trailing Peg Ratio 0.7697
Triggerable 1
Two Hundred Day Average 57.7003
Two Hundred Day Average Change 9.419704
Two Hundred Day Average Change Percent 0.16325226
Type Disp Equity
Volume 758,420
Website https://www.livanova.com
Zip W2 6LG